miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5

Zhi-Gang Yang1, Xu-Dong Ma1, Zhao-Hui He2

  • 1Department of Urology, Baotou Central Hospital, Inner Mongolia Medical University, China.

Abstract

Insights

MicroRNA-483-5p (miR-483-5p) is upregulated in prostate cancer, promoting cell growth and invasion. It targets RBM5, suggesting a miR-483-5p/RBM5 pathway in prostate cancer development.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • Gene Regulation

Background:

  • MicroRNA-483-5p (miR-483-5p) is implicated as a miRNA oncogene in various cancers.
  • The specific role of miR-483-5p in prostate cancer pathogenesis remains underexplored.

Purpose of the Study:

  • To investigate the function of miR-483-5p in prostate cancer.
  • To elucidate the regulatory relationship between miR-483-5p and RBM5 in prostate cancer cells.

Main Methods:

  • Quantitative real-time PCR for miR-483-5p expression analysis.
  • MTT and trans-well invasion assays to assess proliferation and invasion.
  • Western blotting for protein expression analysis.
  • Luciferase reporter assays to confirm RBM5 as a direct target of miR-483-5p.

Main Results:

  • miR-483-5p was significantly upregulated in prostate cancer cell lines and tissues.
  • Inhibition of miR-483-5p suppressed prostate cancer cell proliferation and invasion.
  • miR-483-5p directly targets the 3' untranslated region of RBM5.
  • RBM5 overexpression counteracted the pro-growth and pro-invasion effects of miR-483-5p.

Conclusions:

  • A novel miR-483-5p/RBM5 regulatory axis is identified in prostate cancer.
  • This pathway contributes to the development and progression of prostate cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K